Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Sarcoma 19Fibrosarcoma 8Leiomyosarcoma 7Sarcoma, Synovial 6Rhabdomyosarcoma 6Neurofibrosarcoma 6Lymphoma 6Liposarcoma 6Histiocytoma, Malignant Fibrous 6Hemangiosarcoma 6Osteosarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Malignant mesenchymal tumor 5Hemangiopericytoma, Malignant 5Burkitt Lymphoma 4Testicular Neoplasms 3Teratoma 3Sarcoma, Ewing 3Sarcoma, Alveolar Soft Part 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Carcinoma, Embryonal 3Wilms Tumor 2Sarcoma, Endometrial Stromal 2Pheochromocytoma 2Neuroblastoma 2Neoplasm Metastasis 2Leukemia 2

Interventions

Paclitaxel 15Carboplatin 15Taxes 9Cisplatin 8Topotecan 4Docetaxel 4Filgrastim 3pegfilgrastim 2paclitaxel poliglumex 2liposomal doxorubicin 2Methods 2Gemcitabine 2GEN-1 2Etoposide 2Erlotinib Hydrochloride 2Educational Status 2Early Intervention, Educational 2Chemotherapy, Adjuvant 2vandetanib 1rilotumumab 1oregovomab 1motesanib diphosphate 1elesclomol 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Watchful Waiting 1VTX-2337 1Trabectedin 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Fallopian Tube Neoplasms × Ifosfamide × Clear all
NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

GOG Foundation

Phase 3 Unknown
637 enrolled 18 charts
GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡